Weight Loss Clinical Trials in Florida

19 recruiting studies across 4 cities

Browse by City

Miami

All Trials in Florida

Phase

Trial	Phase	Sponsor	Dist.
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight	Phase 3	Novo Nordisk A/S	<1 mi
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight	Phase 3	Novo Nordisk A/S	<1 mi
Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass	N/A	Boston Scientific Corporation	<1 mi
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain	Phase 3	Novo Nordisk A/S	<1 mi
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain	Phase 3	Novo Nordisk A/S	<1 mi
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight	Phase 3	Novo Nordisk A/S	<1 mi
A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet	Phase 1	Novo Nordisk A/S	<1 mi
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia	Phase 1	AVEO Pharmaceuticals, Inc.	<1 mi
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss	Phase 3	Novo Nordisk A/S	<1 mi
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus	Phase 2	Corxel Pharmaceuticals	<1 mi
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea	Phase 3	Novo Nordisk A/S	<1 mi
RESCUE: Discontinuation of GLP-1	—	Boston Scientific Corporation	<1 mi
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients	Phase 4	University of Miami	<1 mi
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D	Phase 1	Alveus Therapeutics, Inc.	<1 mi
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes	Phase 1	Eli Lilly and Company	<1 mi
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss	Phase 2	Veru Inc.	<1 mi
Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Colorectal Cancer Undergoing Chemotherapy	Phase 2	Endevica Bio	4 mi
Visugromab in Cachexia International Trial	Phase 2/3	CatalYm GmbH	24 mi
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea	Phase 3	Novo Nordisk A/S	32 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.